A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion
Status:
Completed
Trial end date:
2015-03-30
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of OZURDEX® (700 µg dexamethasone implant)
in patients with macular edema associated with branch retinal vein occlusion.